Tuberculous meningitis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Tuberculous Meningitis == | |||
[[File:Tuberculous-meningitis-scan.jpg|thumb|MRI scan showing tuberculous meningitis]] | |||
Tuberculous meningitis | [[File:Tuberculous-meningitis-autopsy.jpg|thumb|Autopsy findings in tuberculous meningitis]] | ||
== Symptoms == | '''Tuberculous meningitis''' is a form of [[meningitis]] caused by [[Mycobacterium tuberculosis]], the bacterium responsible for [[tuberculosis]]. It is a serious condition that affects the [[meninges]], the protective membranes covering the [[brain]] and [[spinal cord]]. | ||
The symptoms of tuberculous meningitis can | |||
== Signs and Symptoms == | |||
The symptoms of tuberculous meningitis can develop gradually over several weeks. Early symptoms may include [[fever]], [[headache]], [[nausea]], and [[vomiting]]. As the disease progresses, patients may experience [[neck stiffness]], [[confusion]], [[seizures]], and [[coma]]. | |||
== Pathophysiology == | |||
Tuberculous meningitis occurs when Mycobacterium tuberculosis spreads from the lungs to the [[central nervous system]]. The bacteria can enter the [[bloodstream]] and reach the meninges, causing inflammation and the formation of [[tuberculomas]]. This inflammation can lead to increased [[intracranial pressure]] and [[hydrocephalus]]. | |||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of tuberculous meningitis | |||
Diagnosis of tuberculous meningitis is challenging and often requires a combination of clinical assessment, [[cerebrospinal fluid]] (CSF) analysis, and imaging studies such as [[MRI]] or [[CT scan]]. CSF analysis typically shows elevated [[protein]] levels, low [[glucose]] levels, and a high [[white blood cell]] count with a predominance of [[lymphocytes]]. | |||
== Treatment == | == Treatment == | ||
The treatment of tuberculous meningitis involves a prolonged course of [[antitubercular therapy]] (ATT), which includes drugs such as [[isoniazid]], [[rifampicin]], [[pyrazinamide]], and [[ethambutol]]. [[Corticosteroids]] may also be used to reduce inflammation and prevent complications. | |||
== Prognosis == | == Prognosis == | ||
== | The prognosis of tuberculous meningitis depends on the stage at which treatment is initiated. Early diagnosis and treatment are crucial for a favorable outcome. Delayed treatment can lead to severe neurological damage or death. | ||
== Epidemiology == | |||
Tuberculous meningitis is more common in regions with high rates of tuberculosis, such as [[sub-Saharan Africa]] and [[Southeast Asia]]. It is also more prevalent in individuals with [[HIV/AIDS]] due to their compromised immune systems. | |||
== Related Pages == | |||
* [[Tuberculosis]] | * [[Tuberculosis]] | ||
* [[Meningitis]] | * [[Meningitis]] | ||
* [[ | * [[Central nervous system]] | ||
== References == | == References == | ||
{{Reflist}} | |||
[[Category:Infectious diseases]] | [[Category:Infectious diseases]] | ||
[[Category: | [[Category:Neurology]] | ||
[[Category:Tuberculosis]] | [[Category:Tuberculosis]] | ||
Revision as of 20:56, 9 February 2025
Tuberculous Meningitis


Tuberculous meningitis is a form of meningitis caused by Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. It is a serious condition that affects the meninges, the protective membranes covering the brain and spinal cord.
Signs and Symptoms
The symptoms of tuberculous meningitis can develop gradually over several weeks. Early symptoms may include fever, headache, nausea, and vomiting. As the disease progresses, patients may experience neck stiffness, confusion, seizures, and coma.
Pathophysiology
Tuberculous meningitis occurs when Mycobacterium tuberculosis spreads from the lungs to the central nervous system. The bacteria can enter the bloodstream and reach the meninges, causing inflammation and the formation of tuberculomas. This inflammation can lead to increased intracranial pressure and hydrocephalus.
Diagnosis
Diagnosis of tuberculous meningitis is challenging and often requires a combination of clinical assessment, cerebrospinal fluid (CSF) analysis, and imaging studies such as MRI or CT scan. CSF analysis typically shows elevated protein levels, low glucose levels, and a high white blood cell count with a predominance of lymphocytes.
Treatment
The treatment of tuberculous meningitis involves a prolonged course of antitubercular therapy (ATT), which includes drugs such as isoniazid, rifampicin, pyrazinamide, and ethambutol. Corticosteroids may also be used to reduce inflammation and prevent complications.
Prognosis
The prognosis of tuberculous meningitis depends on the stage at which treatment is initiated. Early diagnosis and treatment are crucial for a favorable outcome. Delayed treatment can lead to severe neurological damage or death.
Epidemiology
Tuberculous meningitis is more common in regions with high rates of tuberculosis, such as sub-Saharan Africa and Southeast Asia. It is also more prevalent in individuals with HIV/AIDS due to their compromised immune systems.
Related Pages
References
<references group="" responsive="1"></references>